| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPXL | IMPAX LABORATORIES INC | Wilkinson George Fred | Chief Executive Officer | Apr 29, 2016 | Option Exercise | $33.35 | 97,219 | 3,242,254 | 429,237 | Dec 23, 2016, 02:34 PM | |
| IPXL | IMPAX LABORATORIES INC | Wilkinson George Fred | Chief Executive Officer | Apr 29, 2016 | Option Exercise | $33.35 | 61,594 | 2,054,160 | 464,862 | May 02, 2016, 12:45 PM | |
| IPXL | IMPAX LABORATORIES INC | Wilkinson George Fred | Chief Executive Officer | Feb 26, 2016 | Option Exercise | $33.27 | 5,567 | 185,214 | 437,124 | Mar 01, 2016, 04:10 PM | |
| IPXL | IMPAX LABORATORIES INC | Wilkinson George Fred | Chief Executive Officer | Oct 29, 2015 | Option Exercise | $35.75 | 16,425 | 587,194 | 442,691 | Oct 30, 2015, 02:06 PM | |
| IPXL | IMPAX LABORATORIES INC | Wilkinson George Fred | Chief Executive Officer | Apr 29, 2015 | Option Exercise | $46.36 | 114,803 | 5,322,267 | 459,116 | May 01, 2015, 03:14 PM | |
| IPXL | IMPAX LABORATORIES INC | Wilkinson George Fred | Chief Executive Officer | Oct 29, 2014 | Option Exercise | $28.19 | 19,081 | 537,893 | 505,919 | Oct 31, 2014, 12:39 PM | |
| ACT | Actavis plc | Wilkinson George Fred | PRES-ACTAVIS SPECIALTY BRANDS | Nov 27, 2013 | Sale | $165.00 | 24,217 | 3,995,805 | 15,412 | Dec 02, 2013, 06:09 PM | |
| ACT | Actavis plc | Wilkinson George Fred | PRES-ACTAVIS SPECIALTY BRANDS | Nov 22, 2013 | Sale | $165.00 | 4,281 | 706,365 | 41,131 | Nov 26, 2013, 05:42 PM | |
| ACT | Actavis plc | Wilkinson George Fred | PRES-ACTAVIS SPECIALTY BRANDS | Nov 25, 2013 | Sale | $165.00 | 1,502 | 247,830 | 39,629 | Nov 26, 2013, 05:42 PM | |
| ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands&Biosimilars | Sep 30, 2013 | Option Exercise | $144.00 | 43,429 | 6,253,776 | 45,412 | Oct 02, 2013, 09:17 PM | |
| ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands&Biosimilars | Sep 21, 2013 | Option Exercise | $135.50 | 3,240 | 439,020 | 49,229 | Sep 24, 2013, 06:01 PM | |
| ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands&Biosimilars | Sep 04, 2013 | Sale | $138.00 | 16,749 | 2,311,362 | 52,469 | Sep 06, 2013, 04:05 PM | |
| ACT | Actavis, Inc. | Wilkinson George Fred | Pres-Global Brands&Biosimilars | Mar 02, 2013 | Option Exercise | $85.54 | 5,554 | 475,089 | 55,133 | Mar 05, 2013, 07:26 PM | |
| WPI | WATSON PHARMACEUTICALS INC | Wilkinson George Fred | Exec.VP-Global Brands | Feb 24, 2012 | Option Exercise | $58.17 | 1,956 | 113,781 | 40,624 | Feb 28, 2012, 12:25 PM | |
| WPI | WATSON PHARMACEUTICALS INC | Wilkinson George Fred | Exec.VP-Global Brands | Sep 21, 2011 | Option Exercise | $70.04 | 2,028 | 142,041 | 42,580 | Sep 22, 2011, 04:40 PM |
Menu